Here, we report that RKIP reduction is associated with NPC radioresistance and poor patient prognosis, and reduced RKIP promotes NPC radioresistance by increasing ERK and AKT signaling activity. The gene discussed is MAPK1; the disease is nasopharyngeal carcinoma.